Tumor infection by oncolytic reovirus primes adaptive anti-tumor immunity

PURPOSE: Early clinical trials are underway exploring the direct oncolytic potential of reovirus. This study addresses whether tumor infection by reovirus is also able to generate bystander, adaptive anti-tumor immunity. EXPERIMENTAL DESIGN: Reovirus was delivered iv. to C57Bl/6 mice bearing lymph n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Prestwich, RJ, Errington, F, Ilett, EJ, Morgan, R, Scott, K, Kottke, T, Thompson, J, Morrison, EE, Harrington, KJ, Pandha, HS, Selby, PJ, Vile, RG, Melcher, AA
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2701231/
https://ncbi.nlm.nih.gov/pubmed/19010851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0831
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller